1. |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 2016, 315(8): 801-810.
|
2. |
Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med, 2015, 41(8): 1411-1423.
|
3. |
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA, 2005, 294(7): 813-818.
|
4. |
Liu J, Xie H, Ye Z, et al. Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis. BMC Nephrol, 2020, 21(1): 318.
|
5. |
Wong ET, Ong V, Remani D, et al. Filter life and safety of heparin-grafted membrane for continuous renal replacement therapy. A randomized controlled trial. Semin Dial, 2021, 34(4): 300-308.
|
6. |
Broman ME, Hansson F, Vincent JL, et al. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One, 2019, 14(8): e0220444.
|
7. |
Feng J, Zhang S, Ai T, et al. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: a pilot randomized controlled trial. Int J Artif Organs, 2022, 45(10): 801-808.
|
8. |
Pickkers P, Vassiliou T, Liguts V, et al. Sepsis management with a blood purification membrane: European experience. Blood Purif, 2019, 47(Suppl 3): 36-44.
|
9. |
Ma S, Evans RG, Iguchi N, et al. Sepsis-induced acute kidney injury: a disease of the microcirculation. Microcirculation, 2019, 26(2): e12483.
|
10. |
Doi K, Nishida O, Shigematsu T, et al. The Japanese clinical practice guideline for acute kidney injury 2016. Clin Exp Nephrol, 2018, 22(5): 985-1045.
|
11. |
朱倩莹, 程立新, 黄兰, 等. 甲磺酸萘莫司他体外抗凝在脓毒症合并急性肾损伤患者连续性肾脏替代治疗中的应用评价. 华西医学, 2023, 38(5): 718-723.
|
12. |
Zarbock A, Nadim MK, Pickkers P, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol, 2023, 19(6): 401-417.
|
13. |
Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care, 2020, 10(1): 32.
|
14. |
Vlaar APJ, Dionne JC, de Bruin S, et al. Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med, 2021, 47(12): 1368-1392.
|
15. |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 2021, 47(11): 1181-1247.
|
16. |
北村伸哉, 张凌. 甲磺酸萘莫司他在连续性肾脏替代治疗中的抗凝应用. 华西医学, 2018, 33(7): 801-805.
|
17. |
Feng Y, Peng JY, Peng Z. Blood purification in sepsis and systemic inflammation. Curr Opin Crit Care, 2021, 27(6): 582-586.
|
18. |
Zarbock A, Küllmar M, Kindgen-Milles D, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA, 2020, 324(16): 1629-1639.
|
19. |
Pellizzari L, Facchinetti R, Corrà L, et al. Can we reliably predict the level of anticoagulation after enoxaparin injection in elderly patients with renal failure?. Aging Clin Exp Res, 2018, 30(6): 605-608.
|
20. |
中华医学会肾脏病学分会专家组. 连续性肾脏替代治疗的抗凝管理指南. 中华肾脏病杂志, 2022, 38(11): 1016-1024.
|
21. |
李江涛, 王立瑞, 李馨, 等. oXiris 滤器-连续性肾脏替代治疗应用甲磺酸萘莫司他抗凝 1 例体会. 中华肾脏病杂志, 2022, 38(8): 731-733.
|
22. |
Hirayama T, Nosaka N, Okawa Y, et al. AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study. J Intensive Care, 2017, 5: 46.
|
23. |
Romagnoli S, Ricci Z, Ronco C. Renal replacement therapy during septic renal dysfunction//Vincent JL. Annual update in intensive care and emergency medicine. Cham: Springer, 2019: 365-382.
|
24. |
Hellman T, Uusalo P, Järvisalo MJ. Renal replacement techniques in septic shock. Int J Mol Sci, 2021, 22(19): 10238.
|
25. |
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp, 2018, 6(1): 12.
|
26. |
李江涛, 王爱丽, 王立瑞, 等. oXiris 滤器在脓毒症急性肾损伤治疗中的应用评价: 病例系列研究. 中华肾脏病杂志, 2021, 37(10): 831-834.
|
27. |
Iba T, Levy JH, Levi M. Viral-induced inflammatory coagulation disorders: preparing for another epidemic. Thromb Haemost, 2022, 122(1): 8-19.
|
28. |
Griffin BR, Jovanovich A, You Z, et al. Effects of baseline thrombocytopenia and platelet decrease following renal replacement therapy initiation in patients with severe acute kidney injury. Crit Care Med, 2019, 47(4): e325-e331.
|
29. |
Zhang L, Yan Tang GK, Liu S, et al. Hemofilter with adsorptive capacities: case report series. Blood Purif, 2019, 47(Suppl 3): 45-50.
|